Genomic profiling of B-progenitor acute lymphoblastic leukemia

Best Practice and Research: Clinical Haematology

Volumn 24, Issue 4, 2011, Pages 489-503

  Mullighan, Charles G ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

acute lymphoblastic leukemia; ALL; B progenitor; BCR ABL1 like; CREBBP; CRLF2; genomic profiling; IKZF1; JAK1 2; PAX5

Indexed keywords

ANTINEOPLASTIC AGENT; BCR ABL PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN BINDING PROTEIN; CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; DEXAMETHASONE; EARLY B CELL FACTOR 1; GLUCOCORTICOID; JANUS KINASE 1; JANUS KINASE 2; LYMPHOID ENHANCER FACTOR 1; PROTEIN CRLF2; PROTEIN IKZF1; PROTEIN TYROSINE KINASE INHIBITOR; TRANSCRIPTION FACTOR PAX5; UNCLASSIFIED DRUG; VORINOSTAT;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BLAST CELL CRISIS; CANCER CHEMOTHERAPY; CHILDHOOD LEUKEMIA; CHROMOSOME 21; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CHRONIC MYELOID LEUKEMIA; CYTOGENETICS; EXON; FRAMESHIFT MUTATION; GENE DELETION; GENE DOSAGE; GENE EXPRESSION PROFILING; GENETIC DISORDER; GENETIC VARIABILITY; GENOME ANALYSIS; HETEROZYGOTE; HIGH RISK PATIENT; HUMAN; LEUKEMOGENESIS; MISSENSE MUTATION; NONHUMAN; NONSENSE MUTATION; PRE B LYMPHOCYTE; PRIORITY JOURNAL; RECEPTOR GENE; TUMOR GENE;

EID: 82355170632     PISSN: 15216926     EISSN: 15321924     Source Type: Journal    
DOI: 10.1016/j.beha.2011.09.004     Document Type: Review

References (113)

1. C.H. Pui, and S.C. Howard Current management and challenges of malignant disease in the CNS in paediatric leukaemia Lancet Oncol 9 2008 257 268 (Pubitemid 351722945)
2. A.S. Advani, S.P. Hunger, and A.K. Burnett Acute leukemia in adolescents and young adults Semin Oncol 36 2009 213 226
3. C.H. Pui, W.L. Carroll, and S. Meshinchi Biology, risk stratification, and therapy of pediatric acute leukemias: an update J Clin Oncol 29 2011 551 565
4. C.G. Mullighan, and J.R. Downing Genome-wide profiling of genetic alterations in acute lymphoblastic leukemia: recent insights and future directions Leukemia 23 2009 1209 1218
5. R. Beroukhim, C.H. Mermel, and D. Porter The landscape of somatic copy-number alteration across human cancers Nature 463 2010 899 905
6. T.J. Ley, E.R. Mardis, and L. Ding DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome Nature 456 2008 66 72
7. S.C. Raimondi Cytogenetics of acute leukemias C.H. Pui, Childhood leukemias 2nd ed 2006 Cambridge University Press Cambridge 235 271
8. C.J. Harrison Cytogenetics of paediatric and adolescent acute lymphoblastic leukaemia Br J Haematol 144 2009 147 156
9. C.J. Harrison, A.V. Moorman, and Z.J. Broadfield Three distinct subgroups of hypodiploidy in acute lymphoblastic leukaemia Br J Haematol 125 2004 552 559 (Pubitemid 38747956)
10. N.A. Heerema, J.B. Nachman, and H.N. Sather Hypodiploidy with less than 45 chromosomes confers adverse risk in childhood acute lymphoblastic leukemia: a report from the children's cancer group Blood 94 1999 4036 4045
11. J.B. Nachman, N.A. Heerema, and H. Sather Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia Blood 110 2007 1112 1115 (Pubitemid 47281405)
12. C.H. Pui, D.L. Williams, and S.C. Raimondi Hypodiploidy is associated with a poor prognosis in childhood acute lymphoblastic leukemia Blood 70 1987 247 253 (Pubitemid 17111270)
13. S.C. Raimondi, Y. Zhou, and S. Mathew Reassessment of the prognostic significance of hypodiploidy in pediatric patients with acute lymphoblastic leukemia Cancer 98 2003 2715 2722 (Pubitemid 37509538)
14. S.P. Romana, M. Mauchauffe, and M. Le Coniat The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion Blood 85 1995 3662 3670
15. T.R. Golub, G.F. Barker, and S.K. Bohlander Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukemia Proc Natl Acad Sci U S A 92 1995 4917 4921
16. I. Aifantis, E. Raetz, and S. Buonamici Molecular pathogenesis of T-cell leukaemia and lymphoma Nat Rev Immunol 8 2008 380 390 (Pubitemid 351595220)
17. J.P. Meijerink Genetic rearrangements in relation to immunophenotype and outcome in T-cell acute lymphoblastic leukaemia Best Pract Res Clin Haematol 23 2010 307 318
18. C. Graux, J. Cools, and L. Michaux Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast Leukemia 20 2006 1496 1510 (Pubitemid 44264091)
19. T. Okuda, S.A. Shurtleff, and M.B. Valentine Frequent deletion of p16INK4a/MTS1 and p15INK4b/MTS2 in pediatric acute lymphoblastic leukemia Blood 85 1995 2321 2330
20. A.P. Weng, A.A. Ferrando, and W. Lee Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia Science 306 2004 269 271 (Pubitemid 39336870)
21. C.G. Mullighan, S. Goorha, and I. Radtke Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia Nature 446 2007 758 764 (Pubitemid 46582031)
22. C.G. Mullighan, C.B. Miller, and I. Radtke BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros Nature 453 2008 110 114 (Pubitemid 351630327)
23. R.P. Kuiper, E.F. Schoenmakers, and S.V. van Reijmersdal High-resolution genomic profiling of childhood ALL reveals novel recurrent genetic lesions affecting pathways involved in lymphocyte differentiation and cell cycle progression Leukemia 21 2007 1258 1266 (Pubitemid 46831815)
24. N. Kawamata, S. Ogawa, and M. Zimmermann Molecular allelokaryotyping of pediatric acute lymphoblastic leukemias by high-resolution single nucleotide polymorphism oligonucleotide genomic microarray Blood 111 2008 776 784
25. P. Van Vlierberghe, I. Homminga, and L. Zuurbier Cooperative genetic defects in TLX3 rearranged pediatric T-ALL Leukemia 22 2008 762 770 (Pubitemid 351552625)
26. P. van Vlierberghe, J.P. Meijerink, and C. Lee A new recurrent 9q34 duplication in pediatric T-cell acute lymphoblastic leukemia Leukemia 20 2006 1245 1253 (Pubitemid 43905828)
27. H. Parker, Q. An, and K. Barber The complex genomic profile of ETV6-RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1 Genes Chromosomes Canc 47 2008 1118 1125
28. T.R. Golub, D.K. Slonim, and P. Tamayo Molecular classification of cancer: class discovery and class prediction by gene expression monitoring Science 286 1999 531 537
29. M.E. Ross, X. Zhou, and G. Song Classification of pediatric acute lymphoblastic leukemia by gene expression profiling Blood 102 2003 2951 2959 (Pubitemid 37248870)
30. E.J. Yeoh, M.E. Ross, and S.A. Shurtleff Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling Cancer Cell 1 2002 133 143 (Pubitemid 41039160)
31. C.G. Mullighan Single nucleotide polymorphism microarray analysis of genetic alterations in cancer Methods Mol Biol 730 2011 235 258
32. S. Heinrichs, C. Li, and A.T. Look SNP array analysis in hematologic malignancies: avoiding false discoveries Blood 115 2010 4157 4161
33. K. Paulsson, J.B. Cazier, and F. Macdougall Microdeletions are a general feature of adult and adolescent acute lymphoblastic leukemia: Unexpected similarities with pediatric disease Proc Natl Acad Sci U S A 105 2008 6708 6713 (Pubitemid 351754571)
34. C.G. Mullighan, X. Su, and J. Zhang Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia N Engl J Med 360 2009 470 480
35. M. Bardini, R. Spinelli, and S. Bungaro DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4 Leukemia 24 2010 169 176
36. I. Iacobucci, C.T. Storlazzi, and D. Cilloni Identification and molecular characterization of recurrent genomic deletions on 7p12 in the IKZF1 gene in a large cohort of BCR-ABL1-positive acute lymphoblastic leukemia patients: on behalf of Gruppo Italiano Malattie Ematologiche dell'Adulto Acute Leukemia Working Party (GIMEMA AL WP) Blood 114 2009 2159 2167
37. G. Martinelli, I. Iacobucci, and C.T. Storlazzi IKZF1 (Ikaros) deletions in BCR-ABL1-positive acute lymphoblastic leukemia are associated with short disease-free survival and high rate of cumulative incidence of relapse: a GIMEMA AL WP report J Clin Oncol 27 2009 5202 5207
38. C. Virely, S. Moulin, and C. Cobaleda Haploinsufficiency of the IKZF1 (IKAROS) tumor suppressor gene cooperates with BCR-ABL in a transgenic model of acute lymphoblastic leukemia Leukemia 24 2010 1200 1204
39. L.M. Heltemes-Harris, M.J. Willette, and L.B. Ramsey EBF1 or PAX5 haploinsufficiency synergizes with STAT5 activation to initiate acute lymphoblastic leukemia J Exp Med 208 2011 1135 1149
40. J. Dang, C.G. Mullighan, and L.A. Phillips Retroviral and chemical mutagenesis identifies PAX5 as a tumor suppressor in B-progenitor acute lymphoblastic leukemia Blood 112 2008 1789 ASH Annual Meeting Abstracts
41. J.R. Collins-Underwood, N. Boulos, and D. Payne-Turner The role of dominant-negative IKAROS mutations in the pathogenesis and treatment responsiveness of BCR-ABL1 positive acute lymphoblastic leukemia Blood 116 2010 540 ASH Annual Meeting Abstracts
42. M.L. Den Boer, M. van Slegtenhorst, and R.X. De Menezes A subtype of childhood acute lymphoblastic leukaemia with poor treatment outcome: a genome-wide classification study Lancet Oncol 10 2009 125 134
43. A. Tefferi Novel mutations and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1 Leukemia 24 2010 1128 1138
44. Y.L. Yang, C.C. Hung, and J.S. Chen IKZF1 deletions predict a poor prognosis in children with B-cell progenitor acute lymphoblastic leukemia: a multicenter analysis in Taiwan Cancer Sci 2011
45. R.P. Kuiper, E. Waanders, and V.H. van der Velden IKZF1 deletions predict relapse in uniformly treated pediatric precursor B-ALL Leukemia 24 2010 1258 1264
46. E. Waanders, V.H. van der Velden, and C.E. van der Schoot Integrated use of minimal residual disease classification and IKZF1 alteration status accurately predicts 79% of relapses in pediatric acute lymphoblastic leukemia Leukemia 25 2011 254 258
47. C.G. Mullighan, J.R. Collins-Underwood, and L.A. Phillips Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia Nat Genet 41 2009 1243 1246
48. R.C. Harvey, C.G. Mullighan, and I.M. Chen Rearrangement of CRLF2 is associated with mutation of JAK kinases, alteration of IKZF1, Hispanic/Latino ethnicity, and a poor outcome in pediatric B-progenitor acute lymphoblastic leukemia Blood 115 2010 5312 5321
49. A. Yoda, Y. Yoda, and S. Chiaretti Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia Proc Natl Acad Sci U S A 107 2010 252 257
50. Y.J. Liu Thymic stromal lymphopoietin: master switch for allergic inflammation J Exp Med 203 2006 269 273
51. B. Zhou, M.R. Comeau, and T. De Smedt Thymic stromal lymphopoietin as a key initiator of allergic airway inflammation in mice Nat Immunol 6 2005 1047 1053 (Pubitemid 41486190)
52. S.F. Ziegler, and Y.J. Liu Thymic stromal lymphopoietin in normal and pathogenic T cell development and function Nat Immunol 7 2006 709 714 (Pubitemid 43905869)
53. L.J. Russell, M. Capasso, and I. Vater Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia Blood 114 2009 2688 2698
54. L. Hertzberg, E. Vendramini, and I. Ganmore Down syndrome acute lymphoblastic leukemia: a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the iBFM Study Group Blood 115 2010 1006 1017
55. R.L. Levine, A. Pardanani, and A. Tefferi Role of JAK2 in the pathogenesis and therapy of myeloproliferative disorders Nat Rev Cancer 7 2007 673 683 (Pubitemid 47327415)
56. D. Bercovich, I. Ganmore, and L.M. Scott Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome Lance 372 2008 1484 1492
57. C.G. Mullighan, J. Zhang, and R.C. Harvey JAK mutations in high-risk childhood acute lymphoblastic leukemia Proc Natl Acad Sci U S A 106 2009 9414 9418
58. J. Zhang, C. Mullighan, and R. Harvey Lack of somatic sequence mutations in protein tyrosine kinase genes other than the JAK kinase family in high risk B-precursor childhood acute lymphoblastic leukemia (ALL): a report from the Children's Oncology Group (COG) High-Risk (HR) ALL TARGET Project Blood 116 2010 2752 ASH Annual Meeting Abstracts
59. C.G. Mullighan, R.D. Morin, and J. Zhang Next generation transcriptomic resequencing identifies novel genetic alterations in high-risk (HR) childhood acute lymphoblastic leukemia (ALL): a report from the Children's Oncology Group (COG) HR ALL TARGET Project Blood 114 2009 abstract 704
60. A. McPherson, F. Hormozdiari, and A. Zayed deFuse: an algorithm for gene fusion discovery in tumor RNA-seq data PLoS Comput Biol 7 2011 e1001138
61. J. Wang, C.G. Mullighan, and J. Easton CREST maps somatic structural variation in cancer genomes with base-pair resolution Nat Methods 8 2011 652 654
62. C. Graux, J. Cools, and C. Melotte Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia Nat Genet 36 2004 1084 1089 (Pubitemid 41184470)
63. G. Cirmena, S. Aliano, and G. Fugazza A BCR-JAK2 fusion gene as the result of a t(9;22)(p24;q11) in a patient with acute myeloid leukemia Cancer Genet Cytogenet 183 2008 105 108 (Pubitemid 351707707)
64. S.W. Lane, D.J. Fairbairn, and C. McCarthy Leukaemia cutis in atypical chronic myeloid leukaemia with a t(9;22) (p24;q11.2) leading to BCR-JAK2 fusion Br J Haematol 142 2008 503 (Pubitemid 352020196)
65. N.C. Cross, and A. Reiter Tyrosine kinase fusion genes in chronic myeloproliferative diseases Leukemia 16 2002 1207 1212
66. E. Lierman, and J. Cools ETV6 and PDGFRB: a license to fuse Haematologica 92 2007 145 147 (Pubitemid 46852413)
67. I. Wlodarska, A. Aventin, and J. Ingles-Esteve A new subtype of pre-B acute lymphoblastic leukemia with t(5;12)(q31q33;p12), molecularly and cytogenetically distinct from t(5;12) in chronic myelomonocytic leukemia Blood 89 1997 1716 1722 (Pubitemid 27097466)
68. L.J. Russell, D.G. De Castro, and M. Griffiths A novel translocation, t(14;19)(q32;p13), involving IGH@ and the cytokine receptor for erythropoietin Leukemi 23 2009 614 617
69. C. Shochat, N. Tal, and O.R. Bandapalli Gain-of-function mutations in interleukin-7 receptor-alpha (IL7R) in childhood acute lymphoblastic leukemias J Exp Med 208 2011 901 908
70. F. Baran-Marszak, H. Magdoud, and C. Desterke Expression level and differential JAK2-V617F-binding of the adaptor protein Lnk regulates JAK2-mediated signals in myeloproliferative neoplasms Blood 116 2010 5961 5971
71. T.L. Lasho, A. Pardanani, and A. Tefferi LNK mutations in JAK2 mutation-negative erythrocytosis N Engl J Med 363 2010 1189 1190
72. A. Pardanani, T. Lasho, and C. Finke LNK mutation studies in blast-phase myeloproliferative neoplasms, and in chronic-phase disease with TET2, IDH, JAK2 or MPL mutations Leukemia 24 2010 1713 1718
73. S.T. Oh, E.F. Simonds, and C. Jones Novel mutations in the inhibitory adaptor protein LNK drive JAK-STAT signaling in patients with myeloproliferative neoplasms Blood 116 2010 988 992
74. A. Bersenev, C. Wu, and J. Balcerek Lnk constrains myeloproliferative diseases in mice J Clin Invest 120 2010 2058 2069
75. L. Harewood, H. Robinson, and R. Harris Amplification of AML1 on a duplicated chromosome 21 in acute lymphoblastic leukemia: a study of 20 cases Leukemia 17 2003 547 553 (Pubitemid 36395648)
76. J. Soulier, L. Trakhtenbrot, and V. Najfeld Amplification of band q22 of chromosome 21, including AML1, in older children with acute lymphoblastic leukemia: an emerging molecular cytogenetic subgroup Leukemia 17 2003 1679 1682 (Pubitemid 36986978)
77. H.M. Robinson, C.J. Harrison, and A.V. Moorman Intrachromosomal amplification of chromosome 21 (iAMP21) may arise from a breakage-fusion-bridge cycle Genes Chromosomes Canc 46 2007 318 326 (Pubitemid 46411323)
78. P.B. Sinclair, H. Parker, and Q. An Analysis of a breakpoint cluster reveals insight into the mechanism of intrachromosomal amplification in a lymphoid malignancy Hum Mol Gen 20 2011 2591 2602
79. J.C. Strefford, F.W. van Delft, and H.M. Robinson Complex genomic alterations and gene expression in acute lymphoblastic leukemia with intrachromosomal amplification of chromosome 21 Proc Nat Acad Sci U S A 103 2006 8167 8172 (Pubitemid 43801070)
80. A.V. Moorman, S.M. Richards, and H.M. Robinson Prognosis of children with acute lymphoblastic leukemia (ALL) and intrachromosomal amplification of chromosome 21 (iAMP21) Blood 109 2007 2327 2330 (Pubitemid 46425871)
81. A.V. Moorman, H.M. Ensor, and S.M. Richards Prognostic effect of chromosomal abnormalities in childhood B-cell precursor acute lymphoblastic leukaemia: results from the UK Medical Research Council ALL97/99 randomised trial Lancet Oncol 11 2010 429 438
82. C.G. Mullighan, C.B. Miller, and X. Su ERG deletions define a novel subtype of B-progenitor acute lymphoblastic leukemia Blood 110 2007 691 ASH Annual Meeting Abstracts
83. S.A. Tomlins, D.R. Rhodes, and S. Perner Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer Science 310 2005 644 648 (Pubitemid 41528150)
84. S.C. Raimondi, C.H. Pui, and D.R. Head Cytogenetically different leukemic clones at relapse of childhood acute lymphoblastic leukemia Blood 82 1993 576 580 (Pubitemid 23206124)
85. O. Blau, S. Avigad, and B. Stark Exon 5 mutations in the p53 gene in relapsed childhood acute lymphoblastic leukemia Leuk Res 21 1997 721 729 (Pubitemid 27458624)
86. J. Gump, L. McGavran, and Q. Wei Analysis of TP53 mutations in relapsed childhood acute lymphoblastic leukemia J Pediatr Hematol Oncol 23 2001 416 419 (Pubitemid 33031768)
87. N. Terada, J. Miyoshi, and K. Kawa-Ha Alteration of N-ras gene mutation after relapse in acute lymphoblastic leukemia Blood 75 1990 453 457 (Pubitemid 20035277)
88. C.G. Mullighan, L.A. Phillips, and X. Su Genomic analysis of the clonal origins of relapsed acute lymphoblastic leukemia Science 322 2008 1377 1380 (Pubitemid 352775249)
89. J.J. Yang, D. Bhojwani, and W. Yang Genome-wide copy number profiling reveals molecular evolution from diagnosis to relapse in childhood acute lymphoblastic leukemia Blood 112 2008 4178 4183
90. N. Kawamata, S. Ogawa, and K. Seeger Molecular allelokaryotyping of relapsed pediatric acute lymphoblastic leukemia Int J Oncol 34 2009 1603 1612
91. F.W. van Delft, S. Horsley, and S. Colman Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia Blood 117 2011 6247 6254
92. T. Szczepanski, V.H. van der Velden, and E. Waanders Late recurrence of childhood T-cell acute lymphoblastic leukemia frequently represents a second leukemia rather than a relapse: first evidence for genetic predisposition J Clin Oncol 29 2011 1643 1649
93. F. Notta, C.G. Mullighan, and J.C. Wang Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells Nature 469 2011 362 367
94. K. Anderson, C. Lutz, and F.W. van Delft Genetic variegation of clonal architecture and propagating cells in leukaemia Nature 469 2011 356 361
95. E. Clappier, B. Gerby, and F. Sigaux Clonal selection in xenografted human T cell acute lymphoblastic leukemia recapitulates gain of malignancy at relapse J Exp Med 208 2011 653 661
96. C.G. Mullighan, J. Zhang, and L.H. Kasper CREBBP mutations in relapsed acute lymphoblastic leukaemia Nature 471 2011 235 239
97. A. Giordano, and M.L. Avantaggiati p300 and CBP: partners for life and death J Cell Physiol 181 1999 218 230 (Pubitemid 29463637)
98. R.H. Goodman, and S. Smolik CBP/p300 in cell growth, transformation, and development Genes Dev 14 2000 1553 1577 (Pubitemid 30460905)
99. V.V. Ogryzko, R.L. Schiltz, and V. Russanova The transcriptional coactivators p300 and CBP are histone acetyltransferases Cell 87 1996 953 959 (Pubitemid 26404293)
100. C. Lavau, C. Du, and M. Thirman Chromatin-related properties of CBP fused to MLL generate a myelodysplastic-like syndrome that evolves into myeloid leukemia EMBO J 19 2000 4655 4664
101. E.K. Schorry, M. Keddache, and N. Lanphear Genotype-phenotype correlations in Rubinstein-Taybi syndrome Am J Med Genet A 146A 2008 2512 2519
102. L. Stimson, V. Wood, and O. Khan HDAC inhibitor-based therapies and haematological malignancy Ann Onco 20 2009 1293 1302
103. L. Pasqualucci, D. Dominguez-Sola, A. Chiarenza, G. Fabbri, A. Grunn, and V. Trifonov Inactivating mutations of acetyltransferase genes in B-cell lymphoma Nature 471 2011 189 195
104. R.D. Morin, M. Mendez-Lago, and A.J. Mungall Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma Nature 2011
105. T.J. Ley, L. Ding, and M.J. Walter DNMT3A mutations in acute myeloid leukemia N Engl J Med 363 2010 2424 2433
106. E.R. Mardis, L. Ding, and D.J. Dooling Recurring mutations found by sequencing an acute myeloid leukemia genome N Engl J Med 361 2009 1058 1066
107. E.R. Mardis A decade's perspective on DNA sequencing technology Nature 470 2011 198 203
108. L.R. Trevino, W. Yang, and D. French Germline genomic variants associated with childhood acute lymphoblastic leukemia Nat Genet 41 2009 1001 1005
109. E. Papaemmanuil, F.J. Hosking, and J. Vijayakrishnan Loci on 7p12.2, 10q21.2 and 14q11.2 are associated with risk of childhood acute lymphoblastic leukemia Nat Genet 41 2009 1006 1010
110. A. Gaikwad, C.L. Rye, and M. Devidas Prevalence and clinical correlates of JAK2 mutations in Down syndrome acute lymphoblastic leukaemia Br J Haematol 144 2009 930 932
111. L. Kearney, D. Gonzalez De Castro, and J. Yeung A specific JAK2 mutation (JAK2R683) and multiple gene deletions in Down syndrome acute lymphoblastic leukaemia Blood 113 2008 646 648
112. G. Cario, M. Zimmermann, and R. Romey Presence of the P2RY8-CRLF2 rearrangement is associated with a poor prognosis in non-high-risk precursor B-cell acute lymphoblastic leukemia in children treated according to the ALL-BFM 2000 protocol Blood 115 2010 5393 5397
113. C.H. Pui, M.V. Relling, and J.R. Downing Acute lymphoblastic leukemia N Engl J Med 350 2004 1535 1548